Dataset from A Multicenter, Open-Label, Extension Study to Evaluate the Long-term Safety and Efficacy of Patisiran in Patients With Familial Amyloidotic Polyneuropathy Who Have Completed a Prior Patisiran Clinical Study

The purpose of this study is to evaluate the safety and efficacy of long-term dosing with ALN-TTR02 (patisiran) in participants with transthyretin (TTR) mediated amyloidosis (ATTR).

本研究旨在评估ALN-TTR02（帕蒂西兰，patisiran）长期给药方案用于转甲状腺素蛋白（transthyretin, TTR）介导的淀粉样变性（ATTR）受试者的安全性与有效性。